What is the average price target for NEXTCURE INC (NXTC) stock?
9 analysts have analysed NXTC and the average price target is 18.02 USD. This implies a price increase of 88.1% is expected in the next year compared to the current price of 9.58.
NASDAQ:NXTC • US65343E2072
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NEXTCURE INC (NXTC).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-11-07 | Ladenburg Thalmann | Upgrade | Neutral -> Buy |
| 2025-07-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-07-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-02 | Needham | Reiterate | Buy -> Buy |
| 2024-06-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-03 | Needham | Reiterate | Buy -> Buy |
| 2024-05-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-20 | Needham | Maintains | Buy -> Buy |
| 2023-12-14 | Needham | Maintains | Buy -> Buy |
| 2023-08-08 | HC Wainwright & Co. | Initiate | Buy |
| 2023-08-04 | Needham | Reiterate | Buy -> Buy |
| 2023-05-05 | Needham | Reiterate | Buy |
| 2023-03-03 | Needham | Reiterate | Buy |
| 2022-11-04 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2022-11-04 | Needham | Maintains | Buy |
| 2022-11-04 | Piper Sandler | Maintains | Overweight |
| 2022-08-23 | Truist Securities | Maintains | Buy |
| 2022-05-23 | Piper Sandler | Maintains | Overweight |
| 2022-03-01 | Ladenburg Thalmann | Initiate | Buy |
| 2021-11-05 | Needham | Maintains | Buy |
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.35M | 22.38M 252.44% | -100.00% | 10.506M | 23.052M 119.42% | 40.494M 75.66% | ||||||||
| EBITDA YoY % growth | -21.52M -43.75% | -34.79M -61.66% | -37.82M -8.71% | -74.389M -76.07% | -80.855M -7.81% | -80.539M 10.92% | -86.374M 14.63% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -23.2M -49.20% | -37.48M -61.55% | -41.23M -10.01% | -74.608M -71.65% | -79.245M -7.26% | -69.377M 10.90% | -58.799M 15.05% | -58.425M -1.68% | -45.9M 21.44% | -54.06M -17.78% | -63.495M -17.45% | -58.752M 7.47% | -14.076M 76.04% | |
| Operating Margin | N/A | -590.24% | -184.23% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -604.37% | -254.87% | -34.76% | |
| EPS YoY % growth | N/A | -69.35 | -15.96 76.99% | -31.44 -88.72% | -32.37 -7.17% | -27.85 16.36% | -23.44 12.00% | -16.22 15.82% | -8.29 58.54% | -9.33 -12.55% | -3.41 63.50% | -2.34 31.44% | -0.22 90.39% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.85 60.55% | -2.04 81.93% | -2.11 34.43% | -2.28 -182.07% | -2.21 -19.89% | -2.31 -13.00% | -2.37 -12.08% | -2.44 -6.70% |
| Revenue Q2Q % growth | ||||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.2M 7.17% | -11.22M 58.89% | -11.73M -31.13% | -12.75M -30.68% | -12.495M -22.50% | -13.26M -18.18% | -13.77M -17.39% | -14.535M -14.00% |
All data in USD
9 analysts have analysed NXTC and the average price target is 18.02 USD. This implies a price increase of 88.1% is expected in the next year compared to the current price of 9.58.
NEXTCURE INC (NXTC) will report earnings on 2026-08-05.
The consensus EPS estimate for the next earnings of NEXTCURE INC (NXTC) is -1.85 USD and the consensus revenue estimate is 0 USD.
The number of analysts covering NEXTCURE INC (NXTC) is 9.